Literature DB >> 23102385

Atrial fibrillation in a tertiary care institute - a prospective study.

Rajeev Bhardwaj1.   

Abstract

OBJECTIVE: Atrial fibrillation is the commonest sustained arrhythmia. In western countries the common causes of atrial fibrillation are hypertensive heart disease, dilated cardiomyopathy, and coronary heart disease. Rheumatic heart disease being still common in India, we studied its contribution to atrial fibrillation.
MATERIAL AND METHODS: 137 consecutive patients of atrial fibrillation coming to our hospital were subjected to echocardiography to determine the cause.
RESULTS: Out of 137 patients with atrial fibrillation, 76 were female (55.47%) and 61 were male (44.43%). Mean age was 51.24±15.36 years. Commonest cause of AF was rheumatic heart disease found in 84 (61.31%) patients. Next common causes were hypertensive heart disease in 14 (10.2%) patients and chronic obstructive pulmonary disease (COPD) in 14 (10.2%) patients. Mean left atrial size was 47.8±12.25mm.
CONCLUSION: In our study of patients coming from a rural back ground of North India, more than 60% patients of AF are due to RHD. Hypertensive heart disease and COPD are the next common causes.
Copyright © 2012 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23102385      PMCID: PMC3861218          DOI: 10.1016/j.ihj.2012.07.014

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  9 in total

1.  Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.

Authors:  Robby Nieuwlaat; Alessandro Capucci; A John Camm; S Bertil Olsson; Dietrich Andresen; D Wyn Davies; Stuart Cobbe; Günter Breithardt; Jean-Yves Le Heuzey; Martin H Prins; Samuel Lévy; Harry J G M Crijns
Journal:  Eur Heart J       Date:  2005-10-04       Impact factor: 29.983

2.  Incidence of and risk factors for atrial fibrillation in older adults.

Authors:  B M Psaty; T A Manolio; L H Kuller; R A Kronmal; M Cushman; L P Fried; R White; C D Furberg; P M Rautaharju
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

Review 3.  Thyrotoxicosis and the heart.

Authors:  K A Woeber
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

4.  Epidemiologic features of chronic atrial fibrillation: the Framingham study.

Authors:  W B Kannel; R D Abbott; D D Savage; P M McNamara
Journal:  N Engl J Med       Date:  1982-04-29       Impact factor: 91.245

5.  Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons.

Authors:  C T Sawin; A Geller; P A Wolf; A J Belanger; E Baker; P Bacharach; P W Wilson; E J Benjamin; R B D'Agostino
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

6.  Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.

Authors:  S M Vaziri; M G Larson; E J Benjamin; D Levy
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

7.  Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease.

Authors:  E Diker; S Aydogdu; M Ozdemir; T Kural; K Polat; S Cehreli; A Erdogan; S Göksel
Journal:  Am J Cardiol       Date:  1996-01-01       Impact factor: 2.778

8.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

Authors:  J G F Cleland; K Swedberg; F Follath; M Komajda; A Cohen-Solal; J C Aguilar; R Dietz; A Gavazzi; R Hobbs; J Korewicki; H C Madeira; V S Moiseyev; I Preda; W H van Gilst; J Widimsky; N Freemantle; Joanne Eastaugh; J Mason
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983

9.  The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management.

Authors:  Michael Nabauer; Andrea Gerth; Tobias Limbourg; Steffen Schneider; Michael Oeff; Paulus Kirchhof; Andreas Goette; Thorsten Lewalter; Ursula Ravens; Thomas Meinertz; Günter Breithardt; Gerhard Steinbeck
Journal:  Europace       Date:  2009-01-18       Impact factor: 5.214

  9 in total
  7 in total

1.  Prevalence of atrial fibrillation in an urban population in India: the Nagpur pilot study.

Authors:  Daljeet Kaur Saggu; Gomathi Sundar; Sandeep G Nair; Varun C Bhargava; Krishnamohan Lalukota; Sridevi Chennapragada; Calambur Narasimhan; Sumeet S Chugh
Journal:  Heart Asia       Date:  2016-04-18

2.  Assessment of atrial electromechanical delay using tissue Doppler echocardiography in children with asthma.

Authors:  Murat Ciftel; Osman Yılmaz; Fırat Kardelen; Hasan Kahveci
Journal:  Pediatr Cardiol       Date:  2014-01-14       Impact factor: 1.655

Review 3.  Global epidemiology of atrial fibrillation.

Authors:  Faisal Rahman; Gene F Kwan; Emelia J Benjamin
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

Review 4.  The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulants.

Authors:  Jamshed Dalal; Abhay Bhave; Abraham Oomman; Amit Vora; Anil Saxena; Dhiman Kahali; Fali Poncha; D S Gambhir; Jaydip Ray Chaudhuri; Nakul Sinha; Saumitra Ray; S S Iyengar; Suvro Banerjee; Upendra Kaul
Journal:  Indian Heart J       Date:  2015-11-24

5.  Atrial fibrillation among the black population in a Ugandan tertiary hospital.

Authors:  Charles Lugero; Davis Kibirige; James Kayima; Charles Kizza Mondo; Jurgen Freers
Journal:  Int J Gen Med       Date:  2016-06-08

6.  The Effect of Bronchial Asthma on Interatrial Electromechanical Delay Coupling Obtained Using Tissue Doppler Imaging.

Authors:  Yazdan Ghandi; Danial Habibi; Mohammad Abasi
Journal:  Iran J Med Sci       Date:  2019-05

7.  Clinical Features, Risk Factors, and Short-term Outcome of Ischemic Stroke, in Patients with Atrial Fibrillation: Data from a Population-based Study.

Authors:  William G Akanksha; Kaur Paramdeep; Singh Gagandeep; Bansal Rajinder; S Paul Birinder; Singla Monika; Singh Shavinder; J Samuel Clarence; J Verma Shweta; Meenakshi Sharma; D Pandian Jeyaraj
Journal:  Ann Indian Acad Neurol       Date:  2017 Jul-Sep       Impact factor: 1.383

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.